CHI3L1(YKL40) has been found to be elevated in the synovial fluid and serum of osteoarthritis patients, suggesting its involvement in the disease process, and the use of CHI3L1(YKL40) as a target for therapy in osteoarthritis is a topic of ongoing research [65,76]. Here, CHI3L1 is linked to osteoarthritis.